DCB has been hinting at being excited by results. KoLs are obviously eyes on as are others. The announcement is also pretty clear about compelling results.
I think the response rate is 5+.
This places it at between 25-50% (5-10/20).
In heavily pretreated patients this is still excellent.
2020, IIRC was 30-40% was it not? (I dont have time to dig out the ann).
This seems fairly consistent and fits neatly for my speculation.
Either way, this Ann has not given me any concerns and only served to firm my convictions and onwards we go.
I said a few years ago after decline from ATH that I think the next time we see ATH will only be on the back of undeniable success to the flock and we will soar straight past it.
While I'm frustrated by the clear BS that is the SP games, im not losing sleep over my investment here.
Ann: H1 2023 Preclinical and Clinical Programs Update, page-37
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.54 |
Change
-0.015(0.97%) |
Mkt cap ! $261.5M | |||
| Open | High | Low | Value | Volume |
| $1.55 | $1.55 | $1.50 | $111.4K | 73.35K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.56 | 1400 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |